Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A in vascular erectile dysfunction
NCT03355963Phase 2Completed
- Sponsor
- Benha University
- Start
- Jul 2016
- Primary completion
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised trial of botulinum toxin type A in erectile dysfunction (ED), sponsored by Benha University. Primary endpoint: International Index of Erectile Function - Erectile Function domain at 6 months. Started Jul 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT03355963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03355963.